Ads
related to: pfizer- Quality by Design
A holistic, proactive approach
to drug development. Learn more.
- Pharma Services Overview
Download our
free brochure.
- Biologics Development
Increase batch yield and reduce
processing time.
- Pharma Trends Whitepaper
Get a CDMO's perspective on the
pharma trends you need to know.
- In-house vs. Outsource?
Download this decision-making guide
for biologics development.
- Early Development Paper
Learn how we can solve even your
your most complex challenges.
- Quality by Design
Search results
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga· 6 days agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s PFE experimental gene...
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg· 7 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued...
Benzinga· 6 days agoPfizer Inc PFE has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks...
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 7 days agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
Pfizer reports fatality in Phase II DMD gene therapy study
Clinical Trials Arena via Yahoo Finance· 7 days agoPfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene...
Q1 2024 Syros Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 47 minutes agoWe did not recognize any revenue in the first quarter of 2024 as compared to $3 million for the first quarter of 2023. The decrease reflects the termination of Syros's collaboration agreement ...
Child dies in gene therapy trial; Pfizer pauses study
Becker’s Hospital Review· 7 days agoA boy has died in Pfizer's phase 2 study of its gene therapy candidate for Duchenne muscular dystrophy, a rare genetic disorder that primarily affects boys, according to a ...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 15 hours agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Investing in Pfizer Inc.
Knox Daily· 2 days agoIn a filing, Pfizer Inc. revealed its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 shares ...
Pfizer Agrees to Settle 10,000 Zantac Lawsuits Over Alleged Cancer Risks, Bloomberg Reports
Morningstar· 7 days ago-- Pfizer has agreed to settle over 10,000 cases against its heartburn drug Zantac for allegedly hiding cancer-associated risks, Bloomberg reports, citing people familiar ...
